225 related articles for article (PubMed ID: 22280229)
1. The role of CD147 in the invasiveness of follicular thyroid carcinoma cells.
Omi Y; Shibata N; Okamoto T; Obara T; Kobayashi M
Thyroid; 2012 Apr; 22(4):383-94. PubMed ID: 22280229
[TBL] [Abstract][Full Text] [Related]
2. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.
Chen L; Pan Y; Gu L; Nie Z; He B; Song G; Li R; Xu Y; Gao T; Wang S
Exp Biol Med (Maywood); 2013 Aug; 238(8):903-12. PubMed ID: 23828593
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor stimulates matrix metalloproteinase-9 expression and invasion in human follicular thyroid carcinoma cells through Focal adhesion kinase.
Rothhut B; Ghoneim C; Antonicelli F; Soula-Rothhut M
Biochimie; 2007 May; 89(5):613-24. PubMed ID: 17397984
[TBL] [Abstract][Full Text] [Related]
4. RNA interference targeting CD147 inhibits the proliferation, invasiveness, and metastatic activity of thyroid carcinoma cells by down-regulating glycolysis.
Huang P; Chang S; Jiang X; Su J; Dong C; Liu X; Yuan Z; Zhang Z; Liao H
Int J Clin Exp Pathol; 2015; 8(1):309-18. PubMed ID: 25755717
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.
Hoelting T; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Aug; 79(2):401-8. PubMed ID: 8045955
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Jpn J Clin Oncol; 2008 Aug; 38(8):528-33. PubMed ID: 18664479
[TBL] [Abstract][Full Text] [Related]
7. FUT7 promotes the malignant transformation of follicular thyroid carcinoma through α1,3-fucosylation of EGF receptor.
Qin H; Liu J; Yu M; Wang H; Thomas AM; Li S; Yan Q; Wang L
Exp Cell Res; 2020 Aug; 393(2):112095. PubMed ID: 32442537
[TBL] [Abstract][Full Text] [Related]
8. Distinct pattern of oxidative DNA damage and DNA repair in follicular thyroid tumours.
Karger S; Krause K; Engelhardt C; Weidinger C; Gimm O; Dralle H; Sheu-Grabellus SY; Schmid KW; Fuhrer D
J Mol Endocrinol; 2012 Jun; 48(3):193-202. PubMed ID: 22331172
[TBL] [Abstract][Full Text] [Related]
9. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system.
Smit JW; van der Pluijm G; Romijn HA; Löwik CW; Morreau H; Goslings BM
Thyroid; 1999 Sep; 9(9):913-9. PubMed ID: 10524570
[TBL] [Abstract][Full Text] [Related]
10. Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A.
Yeh MW; Rougier JP; Park JW; Duh QY; Wong M; Werb Z; Clark OH
Endocr Relat Cancer; 2006 Dec; 13(4):1173-83. PubMed ID: 17158762
[TBL] [Abstract][Full Text] [Related]
11. The impact of CLAUDIN-1 on follicular thyroid carcinoma aggressiveness.
Zwanziger D; Badziong J; Ting S; Moeller LC; Schmid KW; Siebolts U; Wickenhauser C; Dralle H; Fuehrer D
Endocr Relat Cancer; 2015 Oct; 22(5):819-30. PubMed ID: 26219679
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
Cho Mar K; Eimoto T; Tateyama H; Arai Y; Fujiyoshi Y; Hamaguchi M
Histopathology; 2006 Feb; 48(3):286-94. PubMed ID: 16430475
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells.
Hauck CR; Sieg DJ; Hsia DA; Loftus JC; Gaarde WA; Monia BP; Schlaepfer DD
Cancer Res; 2001 Oct; 61(19):7079-90. PubMed ID: 11585739
[TBL] [Abstract][Full Text] [Related]
14. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinicopathological role of miR146a in thyroid follicular carcinoma.
Pignatti E; Vighi E; Magnani E; Kara E; Roncati L; Maiorana A; Santi D; Madeo B; Cioni K; Carani C; Rochira V; Simoni M; Brigante G
Endocrine; 2019 Jun; 64(3):575-583. PubMed ID: 30701447
[TBL] [Abstract][Full Text] [Related]
16. ST6GalNAcII mediates tumor invasion through PI3K/Akt/NF-κB signaling pathway in follicular thyroid carcinoma.
Miao X; Zhao Y
Oncol Rep; 2016 Apr; 35(4):2131-40. PubMed ID: 26820593
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association.
Ellerbroek SM; Halbleib JM; Benavidez M; Warmka JK; Wattenberg EV; Stack MS; Hudson LG
Cancer Res; 2001 Mar; 61(5):1855-61. PubMed ID: 11280738
[TBL] [Abstract][Full Text] [Related]
18. Similar and divergent patterns in the regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of MMP-1 gene expression in benign and malignant human thyroid cells.
Korem S; Resnick MB; Kraiem Z
J Clin Endocrinol Metab; 1999 Sep; 84(9):3322-7. PubMed ID: 10487706
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of CD147 expression by RNA interference inhibits HT29 cell proliferation, invasion and tumorigenicity in vitro and in vivo.
Li R; Pan Y; He B; Xu Y; Gao T; Song G; Sun H; Deng Q; Wang S
Int J Oncol; 2013 Dec; 43(6):1885-94. PubMed ID: 24064772
[TBL] [Abstract][Full Text] [Related]
20. Involvement of CD147 in overexpression of MMP-2 and MMP-9 and enhancement of invasive potential of PMA-differentiated THP-1.
Zhou J; Zhu P; Jiang JL; Zhang Q; Wu ZB; Yao XY; Tang H; Lu N; Yang Y; Chen ZN
BMC Cell Biol; 2005 May; 6(1):25. PubMed ID: 15904490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
